Diagnosis and Clinical Management of Neurological Disorders Caused by Cytomegalovirus in Aids Patients

References

• Achim C L, Nagra R M, Wang R, Nelson J A, Wiley C A. Detection of cytomegalovirus in cerebrospinal fluid autopsy specimens from AIDS patients. J Infect Dis 1994; 169: 623–627
   PubMedGoogle Scholar
• Anders K H, Guerra W F, Tomiyasu U, Verity M A, Vinters H V. The neuropathology of AIDS. UCLA experience and review. Am J Pathol 1986; 124: 537–558
   PubMed Web of Science ®Google Scholar
• Anderson K P, Fox M C, Brown-Driver V, Martin M J, Azad R F. Inhibition of human cytomegalovirus immediate early gene expression by an antisense oligonucleotide complementary to immediate-early RNA. Antimicrob Agents Chemother 1996; 40: 2004–2011
   PubMed Web of Science ®Google Scholar
• Arribas J R, Clifford D B, Fichtenbaum C J, Commins D L, Oowderly W G, Storch G A. Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system. J Infect Dis 1995; 172: 527–531
   PubMed Web of Science ®Google Scholar
• Arribas J R, Storch G A, Clifford D B, Tselis A C. Cytomegalovirus encephalitis. Ann Intern Medicine 1996; 125: 577–587
   PubMed Web of Science ®Google Scholar
• Baldanti F, Silini E, Sarasini A, Talarico C L, Stanat S C, Biron K K, Furione M, Bono F, Palu G, Gerna G. A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate. J Virol 1995; 69: 796–800
   PubMed Web of Science ®Google Scholar
• Baldanti F, Underwood M R, Stanat S C, Biron K K, Chou S, Sarasini A, Silini E, Gerna G. Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotranspherase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS. J Virol 1996; 170: 1390–1395
   Google Scholar
• Berger D S, Bucher G, Nowak J A, Gomatos P J. Acute primary immunodeficiency virus type 1 infection in a patients with concomitant cytomegalovirus encephalitis. Clin Infect Dis 1996; 23: 66–70
   Google Scholar
• Berman S M, Kim R C. The development of cytomegalovirus encephalitis in AIDS patients receiving ganciclovir. Am J Med 1994; 96: 415–419
   PubMedGoogle Scholar
• Blanshard C, Benhamou Y, Dohin E, Lernestedt J O, Gazzard B G, Katlama C. Treatment of AIDS-associated gastrointestinal cytomegalovirus infection with foscarnet and ganciclovir. J Infect Dis 1995; 172: 622–628
   PubMed Web of Science ®Google Scholar
• Boivin G, Chou S, Quirk M R, Erice A, Jordan M C. Detection of ganciclovir resistance mutations and quantitation of cytomegalovirus (CMV) DNA in leukocytes of patients with fatal diseminated CMV disease. J Infect Dis 1996; 173: 523–528
   PubMed Web of Science ®Google Scholar
• Bowen E F, Griffiths P D, Davey C C, Emery V C, Johnson M A. Cytomegalovirus retinitis in AIDS patients: influence of cytomegaloviral load on response to ganciclovir, time to recurrence and survival. AIDS 1996; 10: 1515–1520
   PubMed Web of Science ®Google Scholar
• Brewster M E, Raghavan K, Pop E, Bodor N. Enhanced delivery of ganciclovir to the brain through the use of redox targeting. Antimicrob Agents Chemother 1994; 38: 817–823
   PubMed Web of Science ®Google Scholar
• Brown F, Arum T, Francis G, Patel M, Malcolm S. Ganciclovir prodrug (RS-79070)-Multiple dose, doseranging study with effect of food. Fourth Conference on Retroviruses and Opportunistic Infections, Washington, DCUSA, 1997, Abstract LB 19.
   Google Scholar
• Buffet R, Agut H, Chieze F, Katlama C, Bolgert F, Devillechabrolle A, Diquet B, Schuller E, Pierrot-Deseilligny C, Gentilini M, et al. Virological markers in the cerebrospinal fluid from HIV-1 -infected individuals. AIDS 1991; 5: 1419–1424
   Google Scholar
• Chiodi F, Norkrans G, Hagberg L, Sonnerborg A, Gaines H, Froland S, Fenyo E M, Norrby E, Vandvik B. Human immunodeficiency virus infection of the brain. II. Detection of intrathecally synthesized antibodies by enzyme linked immunosorbent assay and imprint immunofixation. J Neurol Sci 1988; 87: 37–48
   Google Scholar
• Chou S, Erice A, Colin Jordan M C, Vercellotti G M, Michels K R, Talarico C L, Stanat S C, Biron K K. Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. J Infect Dis 1995; 171: 576–583
   PubMed Web of Science ®Google Scholar
• Cinque P, Vago L, Brytting M, Castagna A, Accordini A, Sundqvist V A, Zanchetta N, Monforte A D, Wahren B, Lazzarin A, et al. Cytomegalovirus infection ofthe central nervous system in patients with AIDS: diagnosis by DNA amplification from cerebrospinal fluid. J Infect Dis 1992; 166: 1408–1411
   PubMed Web of Science ®Google Scholar
• Cinque P, Baldanti F, Vago L, Terreni M R, Lillo F, Furione M, Castagna A, Monforte A D, Lazzarin A, Linde A. Ganciclovir therapy for cyto-megalovims (CMV) infection of the central nervous system in AIDS patients: monitoring by CMV DNA detection in cerebrospinal fluid. J Infect Dis 1995; 171: 1603–1606
   Google Scholar
• Cinque P, Vago L, Dahl H, Brytting M, Terreni M R, Fornara C, Racca S, Castagna A, Monforte A D, Wahren B, Lazzarin A, Linde A. Polyrnerase chain reaction on cerebrospinal fluid for diagnosis of virusassociated opportunistic diseases of the central nervous system in HIV-infected patients. AIDS 1996a; 10: 951–958
   PubMed Web of Science ®Google Scholar
• Cinque P, Pisa E, Racca S. Efficacy of different antiviral treatments in cytomegalvirus neurological complications: evaluation by quantitative PCR on cerebrospinal fluid. Third International Congress on Drug Therapy in HIV Infection, Birmingham, UK, 1996b, Abstract OP3.3.
   Google Scholar
• Cinque P, Scarpellini P, Vago L, Linde A, Lazzarin A. Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. AIDS 1997; 11: 1–17
   PubMed Web of Science ®Google Scholar
• Clifford D B, Arribas J R, Storch G A, Tourtellotte W, Wippold F J. Magnetic resonance brain imaging lacks sensitivity for AIDS associated cytomegalovirus encephalitis. J Neurovirol 1996; 2: 397–403
   PubMed Web of Science ®Google Scholar
• Clifford D B, Buller R S, Mohammed S, Robison L, Storch G A. Use of polymerase chain reaction to demonstrate cytomegalovirus DNA in CSF of patients with human immunodeficiency virus infection. Neurology 1993; 43: 75–79
   PubMed Web of Science ®Google Scholar
• Cohen B A, McArthur J C, Grohman S, Patterson B, Glass J D. Neurologic prognosis of cytomegalovirus polyradiculomyelopathy in AIDS. Neurology 1993; 43: 493–499
   Google Scholar
• Cohen B A. Prognosis and response to therapy of cytomegalovirus encephalitis and meningomyelitis in AIDS. Neurology 1996; 46: 444–450
   Google Scholar
• Crumpacker C S. Ganciclovir. N Engl J Med 1996; 335: 721–729
   PubMed Web of Science ®Google Scholar
• Darnell R B. The polymerase chain reaction: application to nervous system disease. Ann Neurol 1993; 34: 513–523
   Google Scholar
• De Gans J, Tiessens G, Portegies P, Tutuarima J A, Troost D. Predominance of polymorphonucleax leukocytes in cerebrospinal fluid of AIDS patients with cytomegalovirus polyradiculomyelitis. J Acquir Immune Defic Syndr 1990; 3: 1155–1158
   Google Scholar
• De Wit S, Snoeck R, Rossi C. Treatment of progressive multifocal leukoencephalopathy with cidofovir in an AIDS patient. Third International Congress on Drug Therapy in HIV Infection, Birmingham, UK, 1996, Abstract P106.
   Google Scholar
• Decker C F, Tarver J H, Murray D F, Martin G J. Prolonged concurrent use of ganciclovir and foscarnet in the treatment of polyradiculopathy due to cytomegalovirus in a patient with AIDS. Clin Infect Dis 1994; 19: 548–549
   Google Scholar
• Dieterich D T, Poles M A, Lew E A, Mendez P E, Murphy R, Addessi A, Holbro J T, Naughton K, Friedberg D N. Concurrent use of ganciclovir and foscarnet to treat cytomegalovirus infection in AIDS patients. J Infect Dis 1993; 167: 1184–1188
   PubMedGoogle Scholar
• Dix R D, Bredesen D E, Erlich K S, Mills J. Recovery of herpesviruses from cerebrospinal fluid of immunodeficient homosexual men. Ann Neurol 1985; 18: 611–614
   PubMedGoogle Scholar
• Domingo P, Puig M, Iranzo A, Lopez-Contreras J, Ris J. Polyradiculopathy due to cytomegalovirus infection: report of a case in which an AIDS patient responded to foscarnet. J Infect Dis 1994; 18: 1019–1020
   Google Scholar
• Drew W L, Miner R, Busch D F, Follansbee S E, Gullett J, Mehalko S G, Gordon S M, Owen W F, Jr, Matthews T R, Buhles W C. Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection. J Infect Dis 1991; 163: 716–719
   PubMed Web of Science ®Google Scholar
• Drew L, Miner R, Garvey J. Documentation of in vivo anti-CMV activity in the cerebrospinal fluid (CSF) by bDNA assay. The Second National Conference on Human Retroviruses and Reiated Infections, Washington, DCUnited States of America, 1995a
   Google Scholar
• Drew W L, Ives D, Lalezari J P, Crumpacker C, Follansbee S E, Spector S A, Benson C A, Friedberg D N, Hubbard L, Stempien M J. for the Syntex Cooperative Oral Ganciclovir Study Group. Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. N Engl J Med 1995b; 333: 615–620
   PubMed Web of Science ®Google Scholar
• Drew W L, Lalezari J, Jordan C. In vivo anticytomegalovirus activity and safety of oral lobucavir in HIV infected patients. Sixth International Cytomegalovirus Workshop, Orange Beach, AlabamaUSA, 1997, Abstract 17.
   Google Scholar
• Ebright J R, Crane L R. Ganciclovir-resistant cytomegalovirs. AIDS 1991; 5: 604
   Google Scholar
• Enting R, De Gans J, Reiss P, Jansen C, Portegies P. Ganciclovir/foscamet for cytomegalovirus meningoencephalitis in AIDS. Lancet 1992; 340: 559–560
   PubMedGoogle Scholar
• Fiala M, Cone L A, Cohen N, Patel D, Williams K, Casareale D, Shapshak P, Tourtelotte W. Responses of neurological complications of AIDS to 3'-azido-3'-deoxythimidine and 9-(1,3-dihydroxy-2-propoxymethyl) guanine. I. Clinical features. Rev Infect Dis 1988; 10: 250–256
   Google Scholar
• Field A K, Tuomari A V, McGeever-Rubin B, Terry B J, Mazina K E, Haffey M L, Hagen M E. (±)-(1 a,2b,3a)-9-[2,3-bis(hydroxymethyl)-cyclobutyl]guanine-[(±)-BHCG or SQ33054]: a potent and selective inhibitor of herpes viruses. Antivir Res 1990; 13: 41–52
   PubMed Web of Science ®Google Scholar
• Fillet A M, Katlama C, Visse B, Camilleri S, Rogeaux O, Huraux J M. Human CMV infection of the CNS: concordance between PCR detection in CSF and pathological examination. AIDS 1993; 7: 1016–1017
   Google Scholar
• Fletcher C, Sawchuck R, Chinnok B, De Miranda P, Balfour H, Jr. Human pharmacokinetics of the antiviral drug DHPG. Clin Pharmacol Ther 1986; 40: 281–286
   PubMed Web of Science ®Google Scholar
• Fox D J, Brink N S, Zuckermann M A, Neild P, Gazzard B G, Tedder R S, Miller R F. Detection of herpesvirus DNA by nested PCR in CSF of HIV-infected persons with neurological disease: a prospective evaluation. J Infect Dis 1995; 172: 1087–1090
   Google Scholar
• Freitas V R, Fraser-Smith E B, Matthews T R. Increased efficacy of ganciclovir in combination with foscarnet against cytomegalovirus and herpes simplex virus type 2 in vitro and in vivo. Antivir Res 1989; 12: 205–212
   PubMed Web of Science ®Google Scholar
• Fuller G N, Jacobs J M, Guiloff R J. Association of painful peripheral neuropathy in AIDS with cytomegalovirus infection. Lancet 1989; 2: 937–941
   Google Scholar
• Fuller G N. Cytomegalovirus and the peripheral nervous system in AIDS. J Acquir Immune Defic Syndr 1992; 5(suppl 1)S33–36
   Google Scholar
• Fuller G N, Jacobs J M, Guiloff R J. Nature and incidence of peripheral nerve syndromes in HIV infection. J Neurol Neurosurg and Psychiatry 1993; 56: 372–381
   Google Scholar
• Gozlan J, Salord J M, Roullet E, Baudrimont M, Caburet F, Picard O, Meyohas M C, Duvivier C, Jacomet C, Petit J. Rapid detection of cytomegalovirus DNA in cerebrospinal fluid of AIDS patients with neurologic disorders. J Infect Dis 1992; 166: 1416–1421
   PubMedGoogle Scholar
• Gozlan J, El Amrami M, Baudrimont M, Costagliola D, Salord J M, Duvivier C, Picard O, Meyohas M C, Jacomet C, Schneider-Fauveau V. A prospective evaluation of clinical criteria and polymerase chain reaction of cerebrospinal fluid for the diagnosis of cytomegalovirus-related neurological diseases during AIDS. AIDS 1994; 9: 253–260
   Google Scholar
• Grafe M R, Wiley C A. Spinal cord and peripheral nerve pathology in AIDS: the roles of cytomegalovirus and human immunodeficiency virus. Ann Neurol 1989; 25: 561–566
   PubMed Web of Science ®Google Scholar
• Hengge U R, Brockmeyer N H, Malessa R, Ravens U, Goos M. Foscarnet penetrates the blood-brain barrier: rationale for therapy of cytomegalovirus encephalitis. Antimicrob Agents Chemother 1993; 37: 1010–1014
   PubMed Web of Science ®Google Scholar
• Holida M D, Trigg M E, Rumelhart N F, Lee N F, Kook H, Peters C. Cytomegalovirus encephalitis resistant to anti-cytomegalovirus therapy. AIDS 1995; 9: 531–532
   Google Scholar
• Holland N R, Power C, Mathews V P, Glass J D, Forman M, McArthur J C. Cytomegalovirus encephalitis in acquired immunodeficiency syndrome (AIDS). Neurology 1994; 44: 507–514
   PubMed Web of Science ®Google Scholar
• Jacobson M A, Kramer F, Bassiakos Y, Hooton T, Polsky B, Geheb H, O'Donnell J J, Walker J D, Korvick J A, Van der Horst C. Randomised phase I trial of two combination foscamet/ganciclovir chronic maintenance therapy regimens for AIDS patients with cytomegalovirus retinitis (AIDS Clinical Trial Group Protocol 151). J Infect Dis 1994; 170: 189–193
   Google Scholar
• Jeantils V, Lemaitre M O, Robert J, Gaudouen Y, Krivitzky A, Delzant G. Subacute polyneuropathy with encephalopathy in AIDS with human cytomegalovirus pathogenicity?. Lancet 1986; 2: 1039
   Google Scholar
• Kalayjian R C, Cohen M L, Bonomo R A, Flanigan T P. Cytomegalovirus ventriculoencephalitis in AIDS. A syndrome with distinct clinical and pathologic features. Medicine 1993; 72: 67–77
   PubMedGoogle Scholar
• Kim Y S, Hollander H. Polyradiculopathy due to cytomegalovirus: report of two cases in which improvement occurred after prolonged therapy and review of the literature. Clin Infect Dis 1993; 17: 32–37
   PubMed Web of Science ®Google Scholar
• Klein J L, Price D A, Fischer M, Coker R J. Cytomegalovirus infection: a possible cause of recurrent transient neurological dysfunction in advanced HIV infection. AIDS 1996; 10: 345–346
   Google Scholar
• Kure K, Llena J F, Lyman W D, Soeiro R, Weidenheim K M, Hirano A, Dickson D W. Human immunodeficiency virus -1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. Hum Pathol 1991; 22: 700–710
   PubMed Web of Science ®Google Scholar
• Lalezari J P, Kemper C, Stagg R. A randomized, controlled study of the safety and efficacy of intravenous cidofovir (CDV, HPMPC) for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS. XI International Conference on AIDS, Vancouver, Canada, 1996, Abstract Th.B.304.
   Google Scholar
• Laskin O L, Cederberg D M, Mills J, Eron L J, Mildvan D, Spector S. Ganciclovir for the treatment and suppression of serious infections caused by cytomegalovirus. Am J Med 1987; 83: 201–207
   PubMed Web of Science ®Google Scholar
• Lea A P, Bryson H M. Cidofovir. Drugs 1996; 52: 225–230
   PubMed Web of Science ®Google Scholar
• Lurain N, Thompson K D, Holmes E W, Read G S. Point mutations in the DNA polymerase gene of human cytomegalovirus that result in resstance to antiviral agents. J Virol 1992; 66: 7146–7152
   PubMed Web of Science ®Google Scholar
• McCutchan J A. Cytomegalovirus infections of the nervous system in patients with AIDS. Clin Infect Dis 1995; 20: 747–754
   PubMed Web of Science ®Google Scholar
• Miller R G, Storey J R, Greco C M. Ganciclovir in the treatment of progressive AIDS-related polyradiculopathy. Neurology 1990; 40: 569–574
   PubMed Web of Science ®Google Scholar
• Miller R F, Lucas S B, Hall-Craggs M A, Brink N S, Scaravilli F, Chinn R J, Kendall B E, Williams I G, Harrison M J. Comparison of magnetic resonance imaging with neuropathological findings in the diagnosis of HIV and CMV associated CNS disease in AIDS. J Neurol Neurosurg Psychiatry 1996; 62: 346–351
   Google Scholar
• Morgello S, Cho E S, Nielsen S, Devinsky O, Petito C K. Cytomegalovirus encephalitis in patients with acquired immunodeficiency syndrome: an autopsy study of 30 cases and a review of the literature. Hum Pathol 1987; 18: 289–97
   PubMed Web of Science ®Google Scholar
• Musiani M, Zerbini M, Venturoli S, Gentilomi G, Borghi V, Pietrosemoli P, Pecorari M, La Place M. Rapid diagnosis of cytomegalovirus encephalitis in patients with AIDS using in situ hybridisation. J Clin Pathol 1994; 47: 886–891
   PubMed Web of Science ®Google Scholar
• Neyts J, Sobis H, Snoeck R, Vandeputte M, De Clercq E. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)-guanine in the treatment of intracerebral murine cytomegalovirus infections in immunocompetent and immunodeficient mice. Eur J Clin Microbiol Infect Dis 1993; 12: 269–279
   Google Scholar
• Oberg B. Antiviral effect of phosphonoformate (PFA, foscamet sodium). Pharmacol Ther 1989; 40: 213–285
   PubMed Web of Science ®Google Scholar
• Palestine A G, Polis M A, De Smet M D. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann Intern Med 1991; 115: 665–673
   PubMed Web of Science ®Google Scholar
• Peters M, Timm U, Schurmann D, Pohle H D, Ruf B. Combined and alternating ganciclovir and foscarnet in acute and maintenance therapy of human immunodeficiency virus-related cytomegalovirus encephalitis refractory to ganciclovir alone. Clin Invest 1992; 70: 456–458
   Google Scholar
• Petito C K, Cho E S, Lemann W, Navia B A, Price R W. Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. J Neuropathol Exp Neurol 1986; 45: 635–646
   PubMed Web of Science ®Google Scholar
• Pollard R B. CMV retinitis: ganciclovir/monoclonal antibody. Antivir Res 1996; 29: 73–75
   PubMed Web of Science ®Google Scholar
• Post M J, Hensley G T, Moskowitz L B, Fischl M. Cytomegalic inclusion virus encephalitis in patients with AIDS: CT, clinical, and pathologic correlation. AJR Am J Roentgenol 1986; 146: 1229–1234
   Google Scholar
• Price T, Digioia R, Simon G. Ganciclovir treatment of cytomegalovirus ventriculitis in a patient infected with human immunodeficiency virus. Clin Infect Dis 1992; 15: 606–608
   PubMedGoogle Scholar
• Raffi F, Taburet A M, Ghaleh B, Huart A, Singlas E. Penetration of foscarnet into cerebrospinal fluid of AIDS patients. Antimicrob Agents Chemother 1993; 37: 1777–1780
   PubMedGoogle Scholar
• Revello M G, Percivalle E, Sarasini A, Baldanti F, Furione M, Gerna G. Diagnosis of human cytomegalovirus infection of the nervous system by pp65 detection in polymorphonuclear leukocytes of cerebrospinal fluid from AIDS patients. J Infect Dis 1994; 170: 1275–1279
   Google Scholar
• Roullet E, Assuems V, Gozlan J, Ropert A, Said G, Baudrimont M, el Amrani M, Jacomet C, Duvivier C, Gonzales-Canali G. Cytomegalovirus multifocal neuropathy in AIDS: analysis of 15 consecutive cases. Neurology 1994; 44: 2174–2182
   Google Scholar
• Said G, Lacroix C, Chemouilli P, Goulon-Goeau C, Roullet E, Penaud D, De Broucker T, Meduri G, Vincent D, Torchet M. Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: a clinical and pathological study. Ann Neurol 1991; 29: 139–146
   Google Scholar
• Salazar A, Podzamczer D, Rene R, Santin M, Perez J L, Ferrer I, Fernandez-Viladrich P, Gudiol F. Cytomegalovirus ventriculoencephalitis in AIDS patients. Scand J Infect Dis 1995; 165–169
   Google Scholar
• Sarasini A, Baldanti F, Furione M, Percivalle E, Brerra R, Barbi M, Gerna G. Double resistance to ganciclovir and foscarnet of four human cytomegalovirus strains recovered from AIDS patients. J Med Virol 1995; 47: 237–244
   Google Scholar
• Schmidbauer M, Budka H, Ulrich W, Ambros P. Cytomegalovirus (CMV) disease of the brain in AIDS and connatal infection: a comparative study by histology, immunocytochemistry and in situ DNA hybridization. Acta Neuropathol 1989; 79: 286–293
   PubMedGoogle Scholar
• Schwarz T F, Loeschke K, Hanus I, Jager G, Feiden W, Stefani F H. CMV encephalitis during ganciclovir therapy of CMV retinitis. Infection 1990; 18: 289–290
   Google Scholar
• Setinek U, Wondrusch E, Jellinger K, Steuer A, Drlicek M, Grisold W, Lintner F. Cytomegalovirus infection of the brain in AIDS-a clinicopathological study. Acta Neuropathol (Berlin) 1995; 90: 511–515
   Google Scholar
• Shepp D H, Dandliker P S, De Miranda P, Burnette T C, Cederberg D M, Kirk L E, Meyers J D. Activity of 9 - [2 - hydroxy-l-(hydroxymethyl)ethoxymethil]guanine in the treatment of cytomegalovirus pneumoniae. Ann Intern Med 1985; 103: 368–373
   PubMed Web of Science ®Google Scholar
• Shinkai M, Spector S A. Quantitation of human cytomegalovirus (HCMV) DNA in cerebrospinal fluid by competitive PCR in AIDS patients with different HCMV central nervous system diseases. Scand J Infect Dis 1995; 27: 559–561
   PubMed Web of Science ®Google Scholar
• Singh N, Anderegg K A, Yu V L. Significance of hypoglycorrhachia in patients with AIDS and cytomegalovirus meningoencephalitis. Clin Infect Dis 1993; 17: 283–284
   Google Scholar
• Sjovall J, Bergdahl S, Movin G, Ogenstad S, Saarimaki M. Pharmacokinetics of foscarnet and distribution to cerebrospinal fluid after intravenous infusion in patients with human immunodeficiency virus infection. Antimicrob Agents Chemother 1989; 32: 1733–1734
   Google Scholar
• Smith I L, Shinkay M, Freeman W R, Spector S A. Polyradiculopathy associated with ganciclovir-resistant cytomegalovirus in an AIDS patient: phenotypic and genotypic characterisation of sequential virus isolates. J Infect Dis 1996; 173: 1481–1484
   PubMed Web of Science ®Google Scholar
• So Y T, Olney R K. Acute lumbosacral polyradiculopathy in acquired immunodeficiency syndrome: experience in 23 patients. Ann Neurol 1994; 35: 53–58
   PubMedGoogle Scholar
• Spector S A, Merrill R, Wolf D, Dankner W M. Detection of human cytomegalovirus in plasma of AIDS patients during acute visceral disease by DNA amplification. J Clin Microbiol 1992; 30: 2359–2365
   PubMed Web of Science ®Google Scholar
• Spector S, Weingeist T, Pollard R B, Dietrich D T, Samo T, Benson C A, Busch D F, Freeman W R, Montague P, Kaplan H J. A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. J Infect Dis 1993; 168: 557–563
   PubMed Web of Science ®Google Scholar
• Spector S A, McKinley G F, Lalezari J P, Samo T, Andruczk R, Follansbee S, Sparti P D, Havlir D V, Simpson G, Buhles W, Wong R, Stempien M, Roche Cooperative Oral Ganciclovir Study Group. Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. N Engl J Med 1996; 334: 1491–1497
   PubMed Web of Science ®Google Scholar
• Stark E, Haas J, Schedel I. Diagnosis of cytomegalovirus infections of the nervous system by immunocytochemical demonstration of infected cells in cerebrospinal fluid. Eur J Med 1993; 2: 223–226
   Google Scholar
• Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. Combination foscarnet and ganciclovir therapy versus monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. Arch Ophtalmol 1996; 114: 23–33
   PubMed Web of Science ®Google Scholar
• Sullivan V, Talarico C L, Stanat S C, Davis M, Coen D M, Biron K K. A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature 1992; 358: 162–164
   PubMed Web of Science ®Google Scholar
• Talpos D, Tien R D, Hesselink J R. Magnetic resonance imaging of AIDS-related polyradiculopathy. Neurology 1991; 41: 1522–1523
   Google Scholar
• Tatarowitcz W A, Lurain N S, Thompson K D. A ganciclovir-resistant ganciclovir isolate of human cytomegalovirus exhibiting cross-resistance to other DNA polymerase inhibitors. J Infect Dis 1992; 166: 904–907
   Google Scholar
• The Oral Ganciclovir European and Australian Cooperative Study Group. Intravenous versus oral ganciclovir: European/Australian comparative study of efficacy and safety in the prevention of cytomegalovirus recurrence in patients with AIDS. AIDS 1995; 9: 471–477
   PubMed Web of Science ®Google Scholar
• Tokumoto J IN, Hollander H. Cytomegalovirus polyradiculoapthy caused by a ganciclovir-resistant strain. Clin Infect Dis 1993; 17: 854–856
   Google Scholar
• Tyler K L. Polymerase chain reaction and the diagnosis of viral central nervous system diseases. Ann Neurol 1994; 6: 809–811
   Google Scholar
• Vago L, Sala E, Nebuloni M, Sala E, Cinque P, Bonetto S, Isella A, Ottoni L, Crociati A, Costanzi G. Coinfection of the central nervous system (CNS) by cytomegalovirus and herpes simplex virus type 1 or 2 in AIDS patients: autopsy study on 82 cases by immunocytochemistry and polymerase chain reaction. Acta Neuropathol (Berlin) 1996; 92: 404–408
   Google Scholar
• Van der Meer J T, Drew W L, Bowden R E, Galasso G J, Griffiths P D, Jabs D A, Katlama C, Spector S A, Whitley R J. Summary of the international consensus symposium on advances in the diagnosis, treatment and prophylaxis of cytomegalovirus infection. Antivir Res 1996; 32: 119–140
   Google Scholar
• Vinters H V, Kwok M K, Ho H W, Anders K H, Tomiyasu U, Wolfson W L, Robert F. Cytomegalovirus in the nervous system of patients with the acquired immune deficiency syndrome. Brain 1989; 112: 245
   PubMed Web of Science ®Google Scholar
• Vogel J U, Cinatl J, Lux A, Weber B, Driesel A J, Doerr H W. New PCR assay for rapid and quantitative detection of human cytomegalovirus in cerebrospinal fluid. J Clin Microbiol 1996; 34: 482–483
   Google Scholar
• Walot I, Miller B L, Chang L, Mehringer C M. Neuroimaging findings in patients with AIDS. Clin Infect Dis 1996; 22: 906–919
   Google Scholar
• Wang L H, Peck R, Chan P Q, Youle M, Eaves J, Bye A. A phase I tolerability and pharmacokinetic trial of 1263 W94, a novel anti-HCMV agent, in HIV-infected volunteers. Fourth Conference on Retroviruses and Opportunistic Infections, Washington, DCUSA, 1997, Abstract 674.
   Google Scholar
• Weber T, Beck R, Stark E, Gerhards K, Korn K, Haas J, Luer W, Jahn G. Comparative analysis of intrathecal antibody synthesis and DNA amplification for the diagnosis of cytomegalovirus infection of the central nervous system in AIDS patients. J Neurol 1994; 241: 407–414
   Google Scholar
• Weber T, Frye S, Bodemer M, Otto M, Luke W. Clinical implications of nucleic acid amplification methods for the diagnosis of viral infections of the nervous system. J Neurovirol 1996; 2: 175
   Web of Science ®Google Scholar
• Wolf D G, Spector S A. Diagnosis of human cytomegalovirus central nervous system disease in AIDS patients by DNA amplification from cerebrospinal fluid. J Infect Dis 1992; 166: 1412–1415
   PubMed Web of Science ®Google Scholar
• Wolf D G, Lee D J, Spector S A. Detection of human cytomegalovirus mutations associated with ganciclovir resistance in cerebrospinal fluid of AIDS patients with central nervous system disease. Antimicrob Agents Chemother 1995; 39: 2552–2554
   Google Scholar
• Zou R M, Ayres K R, Drach J C, Townsend L B. Synthesis and antiviral evaluation of certain disubstituted benzimidazole robonucleosides. J Med Chem 1996; 39: 3477–3482
   PubMed Web of Science ®Google Scholar